Nhung Nguyen

We are drug development team from University of Vienna.
We’re engineering a precision antibiotic that targets resistant gonorrhoeae while leaving the microbiome intact.
Survey is fully anonymous—no patient data.
Your feedback = smarter trials. Thank you!

Clinicians & healthcare profession: anonymous survey to shape an ultra-narrow spectrum antibiotic vs *Neisseria gonorrhoeae*—and spares commensals. Help + share!
👉 Link to survey: forms.gle/RFVaCzzU3dQ4...
Thank you for advancing smarter antibiotics with us!
#Antibiotics #STIs #Gonorrhea

A quinolone N-oxide antibiotic selectively targets Neisseria gonorrhoeae via its toxin–antitoxin system - Nature Microbiology Pseudomonas aeruginosa-derived 2-nonyl-4-quinolone N-oxide exerts bactericidal effects on Neisseria gonorrhoea via zeta1–epsilon1 toxin–antitoxin activation in vitro and abrogates experimental infecti...

nature.com/articles/s41...
On the basis of sex: another important link of toxin/antitoxin systems to the stress response. Here, P. aeruginosa-derived NQNO inhibits N. gonorrhoeae by increasing oxidative stress, activating Zeta1 toxin, without affecting vaginal lactobacilli.

FDA Approves the First New UTI Antibiotic in Nearly 30 Years This antibiotic is the first new FDA-approved medication for urinary tract infections in decades, and meets the need for new treatments in an era of rising antibiotic resistance.

The FDA approved the first new oral antibiotic for uncomplicated UTIs in 30 years, offering a vital treatment option for women and girls aged 12 and up, especially those with #AMR infections. Trials showed mostly mild side effects like diarrhea and nausea.
www.everydayhealth.com/kidney-urina...